Viral infection is a major contributor to the global cancer burden. Recent advances have
revealed that seven known oncogenic viruses promote tumorigenesis through shared host …

Adult T-cell leukemia (ATL) is an aggressive T-cell malignancy caused by human T-cell
leukemia virus type 1 (HTLV-1) that develops through a multistep carcinogenesis process …

Peripheral T cell lymphomas (PTCLs) are a heterogeneous group of orphan neoplasms.
Despite the introduction of anthracycline-based chemotherapy protocols, with or without …

Human T cell leukemia virus type 1 (HTLV-1), also known as human T lymphotropic virus
type 1, was the first exogenous human retrovirus discovered. Unlike the distantly related …

Human T cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia-lymphoma (ATL)
and inflammatory diseases. The HTLV-1 bZIP factor (HBZ) gene is constantly expressed in …

Introduction Aggressive T‐cell lymphomas continue to have a poor prognosis. There are
over 27 different subtypes of peripheral T‐cell lymphoma (PTCL) and we are now beginning …

Introduction Aggressive T‐cell lymphomas continue to have a poor prognosis. There are
over 27 different subtypes of peripheral T‐cell lymphoma (PTCL), and we are now beginning …

Emerging evidence highlights protein acetylation, a prevalent lysine posttranslational
modification, as a regulatory mechanism and promising therapeutic target in human viral …

Human T-cell lymphotropic virus type 1 (HTLV-1) is the causative agent of adult T-cell
leukemia (ATL), an aggressive CD4+/CD25+ T-cell malignancy and of a severe …

Adult T-cell leukemia/lymphoma (ATL) is a malignancy of mature CD4+ T cells induced by
human T-cell leukemia virus type I (HTLV-1). HTLV-1 maintains life-long infection in the …